Navigation Links
Lung Therapy Found To Have Long-Term Side Effects

Based on a recent study , Asian investigators suggest physicians should not recommend dexamethasone therapy because of its adverse effects.//

A therapy routinely given to newborns to prevent or treat chronic lung disease may result in slower neuromotor and cognitive functioning by school age.Previous research shows dexamethasone, a drug known as glucocorticoid, often improves lung function in the short-term and allows for early weaning from mechanical ventilation.

All of the infants in the study had severe respiratory distress syndrome that required mechanical ventilation shortly after birth. Out of 146 children, 72 were given .25 milligrams of dexamethasone per kilogram of body weight intravenously every 12 hours for one week. Then, the dose was tapered over the next three weeks.

Results of the study showed children in the dexamethasone group had significantly poorer motor skills, motor coordination and visual-motor integration than those who did not receive the therapy. Children in the dexamethasone group were also significantly shorter, had smaller head circumferences, and lower IQ scores than those in the control group.The frequency of clinical disabilities was higher among children in the dexamethasone group. In addition, children who received therapy had significantly lower scores on arithmetic, reading, writing and grammar tests than those in the control group.
'"/>




Page: 1

Related medicine news :

1. Cancer Doctors Okays Controversial Prostate Therapy
2. Consensus on "Combination Therapy" for Breast Cancer
3. Gene Therapy shows promise in treating Hemophilia
4. "Make AIDS Therapy affordable" - Physicians demand
5. Hormone replacement Therapy a headache
6. Simple Therapy
7. Therapy for stopping the spread of cancer cells
8. Gene Therapy Destroys Pancreatic Cancer Cells
9. Letrozole Beats Tamoxifen in Breast Cancer Therapy
10. Garlic Supplements Impede HIV Therapy
11. Gene Therapy For Cystic Fibrosis

Post Your Comments:
(Date:11/9/2009)...O, Nov. 9 HUYA Bioscience Intern...ceutical innovation, today announced a strategic p...y, Ocean University of China. The agreement is ano...stablished with China,s leading research and devel...lobal development and commercialization of novel b...
(Date:11/9/2009)...finds that women treated for breast cancer are at ...e breasts. Published in the December 15, 2009 issu...ican Cancer Society, the study,s results indicate ... benefit from additional therapies following surge...te that women with dense breast tissue are at incr...
(Date:11/8/2009)...ON, Nov. 8 Jon O,Brien,...lowing statement about the passage of HR 3962: ,...rican voters a lot about core values. We in the pr...seeking to overcome the struggles ordinary America...t many cannot afford basic healthcare or have to c...
(Date:11/8/2009)...aises House Passage of Health Care Reform Bill ,...e, improve coverage for all Americans ,, HARRI..., SUMMARY: Last night the United States House...form legislation that would strengthen Medicare fo...anies that prices millions of Americans out of aff...
(Date:11/8/2009)...now can take you out of the game later, doctors sa... Foot injuries are the talk of the NFL this season... and running back Willie Parker. , Officials at...erican Academy of Podiatric Sports Medicine are wa...y play fall sports like football and lacrosse. ,...
Breaking Medicine News(10 mins):Health News:HUYA Bioscience International Establishes Strategic Partnership with School of Medicine and Pharmacy, Ocean University of China 2Health News:Breast density associated with increased risk of cancer recurrence 2Health News:Catholics for Choice Statement on Healthcare Reform Bill 2Health News:AARP Pennsylvania Key Vote News Alert 2Health News:AARP Pennsylvania Key Vote News Alert 3Health News:AARP Pennsylvania Key Vote News Alert 4Health News:Rx for Fall Foot Injuries 2
...ages Market Dynamics With New, Plan Offering Thr...om HealthLeaders-InterStudy...udy, a leading provider of managed care market,int...rding to the latest Minnesota Health Plan Analysis...
...ly by Agents, Excellent,Activity Against MRSA, Acc...rces, MALVERN, Pa. and WALTHAM, Mass., Nov. 4 Arl...ces find that with the rising,incidence of skin in...t attribute influencing antibiotic selection in sk...
...:,NTRZ), a world leader in stabilized rice bran (S...oday that it will release its third quarter result...n. Management will host a,conference call at 10:30...al 303-262-2142., The call is also available via ...
...ination rates far below goals, study finds , ...merican adolescents with asthma and other high-ris...ds. , Researchers analyzed vaccination rates from ... rates improved, but only from 8 percent to 15 per...
...gies, Inc. ("Senesco" or the "Company") (NYSE Alte...ll be presenting at the 10th Annual,Rodman & Rensh...he New York,Palace Hotel from November 10-12, 2008... 5:20 PM ET., Rodman & Renshaw is a full-service ...
...XOMA), a leader in the discovery and development o... will host a conference call and webcast on,Monday... third quarter 2008,financial results and provide ...n be accessed via,XOMA,s website at http://www.in...
Other Medicine News:Health News:Minnesota Employers Buck National Trend and Largely Remain Fully-Insured 2Health News:Activity Against MRSA is the Most Important Attribute Influencing Physicians' Antibiotic Selection for the Treatment of Skin and Skin Structure Infections 2Health News:Activity Against MRSA is the Most Important Attribute Influencing Physicians' Antibiotic Selection for the Treatment of Skin and Skin Structure Infections 3Health News:Too Many High-Risk Teens Not Getting Flu Shots 2Health News:Senesco Technologies to Present at 10th Annual Rodman & Renshaw Healthcare Conference 2Health News:Senesco Technologies to Present at 10th Annual Rodman & Renshaw Healthcare Conference 3Health News:XOMA to Announce Third Quarter 2008 Financial Results and Host Conference Call on November 10 2Health News:XOMA to Announce Third Quarter 2008 Financial Results and Host Conference Call on November 10 3
(Date:11/6/2009)...N DIEGO, Nov. 6 Trius Therapeutics...ation statement on Form S-1 with the U.S. Securiti...posed initial public offering of shares of its com...ld in the offering will be offered by the Company....g as sole book-running manager, Piper Jaffray &...
(Date:11/6/2009)...KLAND, Calif., Nov. 6 Kaiser Found...ls (KFHP/H), and their subsidiaries reported today...on for the quarter ended September 30, 2009, compa...year. Operating income in the third quarter was $3...quarter of last year. Net non-operating income was...
(Date:11/6/2009)...RASOTA, Fla., Nov. 6 Ro...d that it has signed a definitive agreement to acq...tary medical devices. The Verathon Board of Direc...is subject to customary regulatory approvals and c... The parties expect the closing to be completed i...
Breaking Medicine Technology:Kaiser Foundation Health Plan and Hospitals Report Third Quarter 2009 Financial Results 2Kaiser Foundation Health Plan and Hospitals Report Third Quarter 2009 Financial Results 3Kaiser Foundation Health Plan and Hospitals Report Third Quarter 2009 Financial Results 4Roper Industries Announces Two Acquisitions to Enhance Growth in Medical and Toll & Traffic Businesses 2Roper Industries Announces Two Acquisitions to Enhance Growth in Medical and Toll & Traffic Businesses 3Exercise helps patients with non alcoholic fatty liver disease 50560 1Exercise helps patients with non alcoholic fatty liver disease 50560 2Axel Ullrich named winner of 2009 Dr Paul Janssen Award for Biomedical Research 9091 1Axel Ullrich named winner of 2009 Dr Paul Janssen Award for Biomedical Research 9091 2Pennsylvania Governor Rendell Ceremonially Signs Four Health Care Bills That Will Reduce Costs Improve Access and Quality 50556 1Pennsylvania Governor Rendell Ceremonially Signs Four Health Care Bills That Will Reduce Costs Improve Access and Quality 50556 2Pennsylvania Governor Rendell Ceremonially Signs Four Health Care Bills That Will Reduce Costs Improve Access and Quality 50556 3Pennsylvania Governor Rendell Ceremonially Signs Four Health Care Bills That Will Reduce Costs Improve Access and Quality 50556 4Pennsylvania Governor Rendell Ceremonially Signs Four Health Care Bills That Will Reduce Costs Improve Access and Quality 50556 5
...June 9 Two long-term, large-scale and,independent...n people with,type 2 diabetes enrolled more than 9...eate) and provide more than 20,000 patient years o... Affairs Diabetes Trial,(VADT), through two separa...VADT, there is no evidence to suggest that use of ...
...., June 9 Radius Health ("Radius"),announced toda...didate,RAD140, from its internal nonsteroidal sele...ry program, for full preclinical development as a,... muscle loss (sarcopenia),and other musculoskeleta...,RAD140 from a series of promising SARMs after it ...
Other Medicine Technology:Two Large, Independent Outcomes Trials Offer New Important Safety Information on Cardiovascular Effects of AVANDIA(R) 2Two Large, Independent Outcomes Trials Offer New Important Safety Information on Cardiovascular Effects of AVANDIA(R) 3Two Large, Independent Outcomes Trials Offer New Important Safety Information on Cardiovascular Effects of AVANDIA(R) 4Radius Selects First Preclinical Candidate From SARM Discovery Program for the Treatment of Muscle Loss and Other Musculoskeletal Conditions 2
WEBeDoctor Physician-office
...lectronic medical records software for healthcare ...fice Records does more than just log patient infor...w of your patient visits, from chronicling patient... new examination records via a series of provider-...
ConnxtMD
Clinicians Desktop
Medicine Products: